Fountainhead AM’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Buy |
15,778
+161
| +1% | +$7.45K | 0.11% | 79 |
|
|
2025
Q1 | $952K | Sell |
15,617
-743
| -5% | -$45.3K | 0.15% | 55 |
|
|
2024
Q4 | $925K | Sell |
16,360
-365
| -2% | -$20.6K | 0.17% | 54 |
|
|
2024
Q3 | $865K | Sell |
16,725
-301
| -2% | -$15.6K | 0.18% | 49 |
|
|
2024
Q2 | $707K | Buy |
17,026
+228
| +1% | +$9.47K | 0.17% | 53 |
|
|
2024
Q1 | $911K | Buy |
16,798
+1,277
| +8% | +$69.3K | 0.22% | 49 |
|
|
2023
Q4 | $796K | Buy |
15,521
+131
| +0.9% | +$6.72K | 0.22% | 50 |
|
|
2023
Q3 | $893K | Sell |
15,390
-432
| -3% | -$25.1K | 0.31% | 34 |
|
|
2023
Q2 | $1.01M | Sell |
15,822
-674
| -4% | -$43.1K | 0.36% | 29 |
|
|
2023
Q1 | $1.14M | Buy |
16,496
+130
| +0.8% | +$9.01K | 0.45% | 27 |
|
|
2022
Q4 | $1.18M | Buy |
16,366
+113
| +0.7% | +$8.13K | 0.53% | 24 |
|
|
2022
Q3 | $1.16M | Buy |
16,253
+1,256
| +8% | +$89.3K | 0.58% | 25 |
|
|
2022
Q2 | $1.16M | Buy |
14,997
+2,724
| +22% | +$210K | 0.63% | 20 |
|
|
2022
Q1 | $896K | Sell |
12,273
-5,120
| -29% | -$374K | 0.4% | 25 |
|
|
2021
Q4 | $1.08M | Buy |
17,393
+150
| +0.9% | +$9.35K | 0.47% | 21 |
|
|
2021
Q3 | $1.02M | Sell |
17,243
-4,692
| -21% | -$278K | 0.49% | 20 |
|
|
2021
Q2 | $1.39M | Sell |
21,935
-1,183
| -5% | -$74.7K | 0.74% | 17 |
|
|
2021
Q1 | $1.46M | Buy |
23,118
+10,289
| +80% | +$649K | 0.78% | 17 |
|
|
2020
Q4 | $796K | Buy |
+12,829
| New | +$796K | 0.5% | 21 |
|